These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7150779

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases.
    Bardou VJ, Arpino G, Elledge RM, Osborne CK, Clark GM.
    J Clin Oncol; 2003 May 15; 21(10):1973-9. PubMed ID: 12743151
    [Abstract] [Full Text] [Related]

  • 3. Oestrogen and progesterone receptors and response to endocrine therapy in Japanese breast cancer.
    Nomura Y, Takatani O, Sugano H, Matsumoto K.
    J Steroid Biochem; 1980 May 15; 13(5):565-6. PubMed ID: 7392632
    [Abstract] [Full Text] [Related]

  • 4. Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer.
    Yu KD, Jiang YZ, Hao S, Shao ZM.
    BMC Med; 2015 Oct 05; 13():254. PubMed ID: 26437901
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.
    Ravdin PM, Green S, Dorr TM, McGuire WL, Fabian C, Pugh RP, Carter RD, Rivkin SE, Borst JR, Belt RJ.
    J Clin Oncol; 1992 Aug 05; 10(8):1284-91. PubMed ID: 1634918
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes of steroid hormone receptor content by chemotherapy and/or endocrine therapy in advanced breast cancer.
    Nomura Y, Tashiro H, Shinozuka K.
    Cancer; 1985 Feb 01; 55(3):546-51. PubMed ID: 3965108
    [Abstract] [Full Text] [Related]

  • 9. Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancer.
    Foekens JA, Portengen H, Look MP, van Putten WL, Thirion B, Bontenbal M, Klijn JG.
    Br J Cancer; 1994 Dec 01; 70(6):1217-23. PubMed ID: 7981080
    [Abstract] [Full Text] [Related]

  • 10. Steroid hormone receptors and clinical usefulness in human breast cancer.
    Nomura Y, Yamagata J, Takenaka K, Tashiro H.
    Cancer; 1980 Dec 15; 46(12 Suppl):2880-3. PubMed ID: 7448732
    [Abstract] [Full Text] [Related]

  • 11. The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients.
    Vollenweider-Zerargui L, Barrelet L, Wong Y, Lemarchand-Béraud T, Gómez F.
    Cancer; 1986 Mar 15; 57(6):1171-80. PubMed ID: 3943040
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.
    Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Pater JL, National Cancer Institute of Canada Clinical Trials Group MA.17.
    J Clin Oncol; 2007 May 20; 25(15):2006-11. PubMed ID: 17452676
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy.
    Jakesz R, Dittrich C, Hanusch J, Kolb R, Lenzhofer R, Moser K, Rainer H, Reiner G, Schemper M, Spona J.
    Ann Surg; 1985 Mar 20; 201(3):305-10. PubMed ID: 3977430
    [Abstract] [Full Text] [Related]

  • 14. Current status of estrogen and progesterone receptors in breast cancer.
    McGuire WL, Horwitz KB, Pearson OH, Segaloff A.
    Cancer; 1977 Jun 20; 39(6 Suppl):2934-47. PubMed ID: 326386
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer.
    Chan M, Chang MC, González R, Lategan B, del Barco E, Vera-Badillo F, Quesada P, Goldstein R, Cruz I, Ocana A, Cruz JJ, Amir E.
    PLoS One; 2015 Jun 20; 10(7):e0132449. PubMed ID: 26161666
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Progesterone receptor status provides predictive value for adjuvant endocrine therapy in older estrogen receptor-positive breast cancer patients.
    Yu KD, Liu GY, Di GH, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM.
    Breast; 2007 Jun 20; 16(3):307-15. PubMed ID: 17293115
    [Abstract] [Full Text] [Related]

  • 18. Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
    Balduzzi A, Bagnardi V, Rotmensz N, Dellapasqua S, Montagna E, Cardillo A, Viale G, Veronesi P, Intra M, Luini A, Pruneri G, Mastropasqua G, Goldhirsch A, Colleoni M.
    Clin Breast Cancer; 2014 Aug 20; 14(4):258-64. PubMed ID: 24325948
    [Abstract] [Full Text] [Related]

  • 19. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J.
    Cancer; 1998 Aug 15; 83(4):698-705. PubMed ID: 9708933
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.